{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:44:50Z","timestamp":1778507090795,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T00:00:00Z","timestamp":1371772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The etiology and immunopathology of multiple sclerosis (MS) is not well understood. It is recognized that although autoreactive T cells are the main early mediators of disease, other cell types, including cells of the innate immune system contribute to MS pathogenesis. The objective of this study was to determine if Toll-like receptor (TLR) signaling is functionally altered in patients with MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Peripheral blood mononuclear cells from healthy donors and patients with relapsing remitting MS were stimulated with specific agonists of TLRs 3, 7, 8 and 9. Using quantitative polymerase chain reaction transcript levels of tumor necrosis factor-\u03b1, interferon-\u03b1 and interleukin (IL)-12\u03b2 were quantified from patients with MS and healthy donors. TLR8-induced production of<jats:italic>IL12B<\/jats:italic>transcripts and protein was functionally impaired in patients with MS as compared to healthy controls (<jats:italic>P<\/jats:italic>&lt;0.05 and<jats:italic>P<\/jats:italic>&lt;0.005, respectively). Patients with MS also expressed lower baseline levels of TLR8 as compared to healthy controls (<jats:italic>P<\/jats:italic>&lt;0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TLR8 expression and signaling is impaired in peripheral blood mononuclear cells from patients with MS. This finding suggests that loss of TLR8 signaling may be contributing to autoimmune processes in MS.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1742-2094-10-74","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T02:18:18Z","timestamp":1371781098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impaired toll-like receptor 8 signaling in multiple sclerosis"],"prefix":"10.1186","volume":"10","author":[{"given":"Tory P","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"Schiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,21]]},"reference":[{"key":"839_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ana.21744","volume":"66","author":"MA Friese","year":"2009","unstructured":"Friese MA, Fugger L: Pathogenic CD8(+) T cells in multiple sclerosis. Ann Neurol 2009, 66:132\u2013141.","journal-title":"Ann Neurol"},{"key":"839_CR2","first-page":"155","volume":"336","author":"MK Racke","year":"2009","unstructured":"Racke MK, Drew PD: Toll-like receptors in multiple sclerosis. Curr Top Microbiol Immunol 2009, 336:155\u2013168.","journal-title":"Curr Top Microbiol Immunol"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nm1202","volume":"11","author":"EJ McMahon","year":"2005","unstructured":"McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD: Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005, 11:335\u2013339.","journal-title":"Nat Med"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.08.010","volume":"239","author":"M Gambuzza","year":"2011","unstructured":"Gambuzza M, Licata N, Palella E, Celi D, Foti Cuzzola V, Italiano D, Marino S, Bramanti P: Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management. J Neuroimmunol 2011, 239:1\u201312.","journal-title":"J Neuroimmunol"},{"key":"839_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.immuni.2010.03.012","volume":"32","author":"AL Blasius","year":"2010","unstructured":"Blasius AL, Beutler B: Intracellular toll-like receptors. Immunity 2010, 32:305\u2013315.","journal-title":"Immunity"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tins.2011.02.005","volume":"34","author":"E Okun","year":"2011","unstructured":"Okun E, Griffioen KJ, Mattson MP: Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011, 34:269\u2013281.","journal-title":"Trends Neurosci"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"e1915","DOI":"10.1371\/journal.pone.0001915","volume":"3","author":"N Funderburg","year":"2008","unstructured":"Funderburg N, Luciano AA, Jiang W, Rodriguez B, Sieg SF, Lederman MM: Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 2008, 3:e1915.","journal-title":"PLoS One"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1191\/1352458502ms817oa","volume":"8","author":"F Ensoli","year":"2002","unstructured":"Ensoli F, Fiorelli V, Lugaresi A, Farina D, De Cristofaro M, Collacchi B, Muratori DS, Scala E, Di Gioacchino M, Paganelli R, Aiuti F: Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. Mult Scler 2002, 8:284\u2013288.","journal-title":"Mult Scler"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2298\/VSP1202151O","volume":"69","author":"D Obradovic","year":"2012","unstructured":"Obradovic D, Kataranovski M, Dincic E, Obradovic S, Colic M: Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis. Vojnosanit Pregl 2012, 69:151\u2013156.","journal-title":"Vojnosanit Pregl"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1196\/annals.1443.012","volume":"1143","author":"M Fischer","year":"2008","unstructured":"Fischer M, Ehlers M: Toll-like receptors in autoimmunity. Ann N Y Acad Sci 2008, 1143:21\u201334.","journal-title":"Ann N Y Acad Sci"},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 2001, 25:402\u2013408.","journal-title":"Methods"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0165-5728(00)00396-9","volume":"112","author":"M Kouwenhoven","year":"2001","unstructured":"Kouwenhoven M, Teleshova N, Ozenci V, Press R, Link H: Monocytes in multiple sclerosis: phenotype and cytokine profile. J Neuroimmunol 2001, 112:197\u2013205.","journal-title":"J Neuroimmunol"},{"key":"839_CR13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1084\/jem.180.3.1159","volume":"180","author":"D Unutmaz","year":"1994","unstructured":"Unutmaz D, Pileri P, Abrignani S: Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994, 180:1159\u20131164.","journal-title":"J Exp Med"},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233\u2013240.","journal-title":"J Exp Med"},{"key":"839_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.184.2.771","volume":"184","author":"BM Segal","year":"1996","unstructured":"Segal BM, Shevach EM: IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 1996, 184:771\u2013775.","journal-title":"J Exp Med"},{"key":"839_CR16","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.4049\/jimmunol.161.9.5097","volume":"161","author":"CS Constantinescu","year":"1998","unstructured":"Constantinescu CS, Wysocka M, Hilliard B, Ventura ES, Lavi E, Trinchieri G, Rostami A: Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 1998, 161:5097\u20135104.","journal-title":"J Immunol"},{"key":"839_CR17","first-page":"3651","volume":"120","author":"O Demaria","year":"2010","unstructured":"Demaria O, Pagni PP, Traub S, de Gassart A, Branzk N, Murphy AJ, Valenzuela DM, Yancopoulos GD, Flavell RA, Alexopoulou L: TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 2010, 120:3651\u20133662.","journal-title":"J Clin Invest"},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.4049\/jimmunol.0802226","volume":"182","author":"X Zhang","year":"2009","unstructured":"Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, Markovic-Plese S: IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol 2009, 182:3928\u20133936.","journal-title":"J Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-10-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-2094-10-74\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-10-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T14:02:52Z","timestamp":1688306572000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-10-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,21]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-10-74","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,21]]},"assertion":[{"value":"14 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"839"}}